Connect with us

Business

Toshiba walked away from potential buyout talks and Brookfield offer -sources

Published

 on

Japan’s Toshiba Corp walked away from potential private equity buyout offers at a substantial premium, as well as advanced talks for a minority stake from Canada’s Brookfield, according to three people familiar with the matter.

Toshiba’s decision to not pursue either course – some details of which have not been previously reported – and instead focus on a plan to split itself in three, has widened the gulf between the conglomerate and a number of its hedge fund investors, according to the people, all of whom declined to be identified because of the sensitivity of the issue.

At least one private equity firm told the Toshiba committee tasked with its strategic review that a deal to take it private could be done at 6,000 yen a share or more, according to two people briefed on the review process.

Another private equity firm told the committee a deal could get done at around 5,000 yen a share, according to one of the people briefed on the review and another person.

A price of 6,000 yen would value Toshiba at around 2.6 trillion yen ($23 billion) and represent a 32% premium to its average price over the past 200 days, according to Refinitiv data.

“We are communicating with shareholders explaining the separation plan we announced on Nov. 12 as well as listening to their opinions,” Toshiba said in a statement to Reuters. “We will continue our communications with various stakeholders.”

Some shareholders have also taken issue with Toshiba’s decision not to pursue talks with Canada’s Brookfield Asset Management, one of the private equity firms, on a potential minority investment, according to several sources.

That could have seen Brookfield, which successfully turned around the conglomerate’s bankrupt nuclear power business Westinghouse, take a minority stake and help overhaul the business, sources said.

Brookfield did not immediate respond to a request for comment.

 

(Reporting by Makiko Yamazaki; Editing by David Dolan and Lincoln Feast.)

Business

Pfizer’s COVID pill is in short supply. Should unvaccinated be prioritized? – Global News

Published

 on


With a limited supply of Pfizer’s new COVID-19 treatment, Paxlovid, bound for Canada, the country’s top doctors have identified groups that should be first in line to get the pills — including unvaccinated older Canadians.

Giving unvaccinated Canadians access to this COVID-19 medication isn’t only the right thing to do, it’s smart public health policy, says one bioethicist.

“It would be ethically unjustifiable, and it would not be scientifically sound to withhold this limited drug from unvaccinated people,” said Dr. Kerry Bowman, a bioethicist at the University of Toronto.

In clinical trial data submitted to Health Canada, the drug was found to reduce risk of hospitalization and death by 89 per cent, according to Dr. Supriya Sharma, Canada’s chief medical adviser.

Read more:

Canada approved Paxlovid, Pfizer’s new oral COVID pill. What you need to know

Ethically speaking, Bowman explained, it’s “very dangerous” to make “judgments” about choices patients make, as well as “about how much health care they can receive based on the choices that they made.”

“It would be a dangerous precedent, and it’s not in alignment with the Canada Health Act,” Bowman said.

As for the science, keeping people out of the hospitals — unvaccinated or not — is key to emerging from the pandemic, he explained.

“From a triage point of view, (vaccination status) is not relevant information…we don’t want highly sick people in the intensive care unit with COVID that don’t have to be there,” Bowman said.

“And so if, in fact, you could avert some of the unvaccinated entering our ICU and taking up space, which is what everyone’s upset and complaining about, all the more reason to do that.”


Click to play video: 'COVID-19: O’Toole says Pfizer’s Paxlovid shipment of 30,000 treatment courses is ‘insufficient’'



1:34
COVID-19: O’Toole says Pfizer’s Paxlovid shipment of 30,000 treatment courses is ‘insufficient’


COVID-19: O’Toole says Pfizer’s Paxlovid shipment of 30,000 treatment courses is ‘insufficient’

Very few courses of this treatment are arriving in Canada in the weeks ahead. Canada has already received an initial shipment of 30,400 treatment courses, Procurement Minister Filomena Tassi said on Monday, and 120,000 more are expected to be delivered between now and the end of March.

There are over 330,000 active cases of the COVID-19 confirmed across the country right now, though that’s considered to be an underestimate.

But far from being the best option for all of those active cases, Paxlovid is only an effective treatment option for a small group of people in Canada to begin with, according to Health Canada. To receive a course of the COVID-19 treatment, an individual must be over 18, and must first test positive for COVID, either with a PCR or a rapid antigen test.

The person must also be within their first five days of having symptoms, and be sick enough to need the medicine without being so sick they need to go to the hospital.

“Paxlovid is just yet another piece of the puzzle that helps us manage this illness in people who may be at more risk,” said Dr. Gerald Evans, an infectious disease specialist at Queen’s University in Kingston, Ont. “For instance, those very small few who are not vaccinated at the moment.”

Read more:

Paxlovid, Pfizer’s oral COVID-19 pill, approved in Canada

Evans added that if you are fully vaccinated, you probably shouldn’t be concerned about others having access to Paxlovid before you.

“If you’re fully vaccinated, you don’t need this drug,” Evans said.

“The effectiveness of vaccination is clearly better than it is for a new antiviral medication like this that’s come out. So being fully vaccinated, you’re way ahead of the game.”

Some individuals who are fully vaccinated might find themselves needing the treatment, such as “an elderly person with a solid organ transplant,” Evans said, but those people are the exception, not the rule.

Who gets priority access to Paxlovid?

The final priority list will be up to the provinces and territories to decide, Health Canada said on Tuesday, but the federal government has provided those regions with “interim implementation considerations” for the first batches of Paxlovid that have arrived.

“(The) first consideration is prioritizing individuals who are at the highest risk for severe illness and hospitalizations,” said Anne Génier, a spokesperson for Health Canada.

Those individuals, Genier added, include immunocompromised Canadians, those over 60 who live in certain at-risk settings and aren’t fully vaccinated, and those over 80 “whose vaccinations are not up to date.”


Click to play video: 'When will Pfizer COVID-19 antiviral treatment arrive in B.C.?'



1:59
When will Pfizer COVID-19 antiviral treatment arrive in B.C.?


When will Pfizer COVID-19 antiviral treatment arrive in B.C.?

Global News contacted every province and territory to determine the criteria they’ll use in deciding who gets first access to the limited supply of Paxlovid.

In Quebec, people who are immunocompromised will be given priority access to the treatment, regardless of their vaccination status, a spokesperson told Global News. New Brunswick’s government, meanwhile, said Paxlovid “will only be provided to individuals who are among the public health priority groups for the time being.”


Click to play video: 'COVID-19: Canada has already received 1st shipment of Pfizer antiviral pill, procurement minister says'



1:24
COVID-19: Canada has already received 1st shipment of Pfizer antiviral pill, procurement minister says


COVID-19: Canada has already received 1st shipment of Pfizer antiviral pill, procurement minister says

Nova Scotia, Ontario, Alberta and British Columbia did not provide specifics on their priority groups. However, Ontario, Alberta and B.C. all said they are currently working to determine eligibility and would have more details to share in the near future.

Manitoba did not directly answer Global News’ question. Newfoundland and Labrador, Prince Edward Island, Saskatchewan, Northwest Territories, Nunavut and Yukon governments did not respond by the time of publication.

At the end of the day, Paxlovid is just another tool in the pandemic toolbox, said Evans.

“I don’t think this is a game changer,” he said.

“What this is about, is yet another very effective tool we can use in a portion of the population.”

© 2022 Global News, a division of Corus Entertainment Inc.

Adblock test (Why?)



Source link

Continue Reading

Business

Airlines worldwide rush to change flights over U.S. 5G dispute – CBC News

Published

 on


Airlines across the world, including the long-haul carrier Emirates, rushed Wednesday to cancel or change flights heading into the U.S. over an ongoing dispute about the rollout of 5G mobile phone technology near American airports.

The issue appeared to impact the Boeing 777, a long-range, wide-body aircraft used by carriers across the world. Two Japanese airlines directly named the aircraft as being particularly affected by the 5G signals as they announced cancellations and changes to their schedules.

Dubai-based Emirates, a key carrier for East-West travel, announced it would halt flights to Boston, Chicago, Dallas-Fort Worth, Houston, Miami, Newark, New Jersey, Orlando, Florida, San Francisco and Seattle over the issue beginning Wednesday. It said it would continue flights to Los Angeles, New York and Washington.

In its announcement, Emirates cited the cancellation as necessary due to “operational concerns associated with the planned deployment of 5G mobile network services in the U.S. at certain airports.”

“We are working closely with aircraft manufacturers and the relevant authorities to alleviate operational concerns, and we hope to resume our U.S. services as soon as possible,” the state-owned airline said.

The United Arab Emirates successfully rolled out 5G coverage all around its airports without incident. But in the U.S., the Federal Aviation Administration worries that the C-Band strand of 5G could interfere with aviation equipment.

A passenger uses a laptop aboard a commercial airline flight from Boston to Atlanta on July 1, 2017. The airline cancellations come even after mobile phone carriers AT&T and Verizon say they will postpone new wireless service near some U.S. airports planned for this week. (Bill Sikes/The Associated Press)

Of particular concern in the 5G rollout appears to be the Boeing 777, a major workhorse for Emirates.

Japan’s All Nippon Airways Co. Ltd. said in a statement that the FAA “has indicated that radio waves from the 5G wireless service may interfere with aircraft altimeters.” Altimeters measure how high a plane is in the sky, a crucial piece of equipment for flying.

“Boeing has announced flight restrictions on all airlines operating the Boeing 777 aircraft, and we have cancelled or changed the aircraft for some flights to/from the U.S. based on the announcement by Boeing,” ANA said.

Japan Airlines Co. Ltd. similarly said that it had been informed that 5G signals “may interfere with the radio altimeter installed on the Boeing 777.”

“We will refrain from using this model on the continental United States line until we can confirm its safety and we regret to inform you that we will cancel the flight for which the aircraft cannot be changed to the Boeing 787,” the airline said.

WATCH | 5G launch delayed near some U.S. airports:

FAA agreement delays 5G rollout near some U.S. airports

9 hours ago

Duration 2:04

The U.S. aviation regulator, the FAA, came to a last-minute deal to avoid turning dozens of airports into no-fly zones for certain planes, but the bigger issue about whether 5G could interfere with airplanes’ ability to land remains unresolved. 2:04

Chicago-based Boeing Co. did not immediately respond to a request for comment.

Air India also announced on Twitter it would cancel flights to Chicago, Newark, New York and San Francisco “due to deployment of the 5G communications” equipment. It said it would try to use other aircraft on U.S. routes as well.

The cancellations come even after mobile phone carriers AT&T and Verizon will postpone new wireless service near some U.S. airports planned for this week.

The FAA will allow planes with accurate, reliable altimeters to operate around high-power 5G. But planes with older altimeters will not be allowed to make landings under low-visibility conditions.

Adblock test (Why?)



Source link

Continue Reading

Business

Leveraging LinkedIn to Get a Job – Part 1

Published

 on

A reader emailed me the following question:

I was an exec at a small oil exploration services company. We closed our doors due to the economy in 2020, and I’ve been trying to pivot since then. I’ve never been on LinkedIn as I was employed for over 30 years at the same company and didn’t feel I needed the exposure. Do you think it’s a detriment/impediment to not be on LinkedIn? 

My answer: Not being on LinkedIn isn’t detrimental to a job search; but it’ll lengthen your job search.

Job seekers gain two advantages by having a complete LinkedIn profile they keep current:

  1. Employers and recruiters find them and approach them with job opportunities (Optimized LinkedIn profile = more views = more opportunities.), and
  2. When short-listed for a job they’ve applied to, their LinkedIn profile, when visited by the employer, which is inevitable, will validate they’re interview-worthy.

According to a September 2020 Forbes article, 95 percent of recruiters use LinkedIn to search for candidates. What’s more efficient for a recruiter; searching LinkedIn and reaching out to qualified candidates or posting a job and being inundated with resumes, many from candidates who don’t meet the job requirements?

To gain every advantage possible during your job search, you must have a LinkedIn profile that’s attractive to employers.

Maximizing your LinkedIn profile requires at minimum doing the following:

  • Keeping your profile current. (Regular updates.)
  • Being comprehensive about your skills.
  • Highlighting your experience, and most importantly, your value to your employers. (Remember, numbers are the language of business, therefore use numbers throughout your profile to support your claims.)

I’ve found the best approach to making the best use of LinkedIn is to be authentic. Be yourself, represent who you are. LinkedIn isn’t your resume. On LinkedIn, you have the opportunity to dynamically represent your experiences (and show your work), skills, career objectives, what you know, and what you’re interested in. However, LinkedIn’s power isn’t dependent on how all-inclusive your profile is; it’s dependent on how current your information is.

In this column, and the next three (a four-part series), I’ll be offering tactical tips on how you can make LinkedIn your job search partner.

My first two tips will immediately boost your LinkedIn profile views.

 

  1. Have a current, no older than 6 months profile picture.

A profile picture is a crucial element of your LinkedIn presence, generating 14 times more page views. In addition, a hiring manager who sees your photo on LinkedIn will develop a specific impression of you. Therefore, it’s critical to consider “strategically” what a person might conclude about your personality and competency from your profile picture.

Job seekers have told me they don’t have a photo because they feel uncomfortable “putting themselves out there” so visibly. Several have said they believe showing a picture of themselves could lead to discrimination because of their age, weight, or race. I tend to look at this last reason from the viewpoint that who you are will become apparent during your first meeting. I’d rather be upfront and be discriminated against, which I won’t really know, than spend my time interviewing only to end up not getting the job due to the interviewer’s bias.

Bottom-line, the lack of a photo keeps your profile from being complete. Complete profiles appear higher in search results than “incomplete” profiles.

  1. Get your headline right.

When people search for you, they only see your photo, name, and headline, which appears beneath your photo. Worth noting, in August 2020, LinkedIn increased the number of headline characters you have from 120 to 220.

When composing your headline, focus on these elements:

  • The role you want. (Use the job title that matches your goal.)
  • Your qualifications.
  • Challenges you enjoy solving.
  • Your track record.

 

EXAMPLES:

  • B2B Inside Sales Representative | $2.7MM generated in 2021 | Digital Ads Manager | 5 years experience managing 7-figure ad budgets | Bilingual (French)
  • Digital Marketing Manager for gaming apps | Increased Subscription Growth From 12k – 55k Users in 8 Months (Without Spending a Dime on Ads) | Google Analytics IQ Certificated

Note: While there is no shame in being unemployed, it’s not a selling point. Employers and recruiters are interested in your skills, not your current employment status. Don’t make the common mistake of adding “Actively Seeking Opportunities” or “Unemployed.” to your headline.

In next week’s column, I’ll be discussing the following:

  • Being comprehensive about your skills.
  • Build your network to the 1st degree.
  • Follow companies you’re interested in joining.

______________________________________________________________

 

Nick Kossovan, a well-seasoned veteran of the corporate landscape, offers advice on searching for a job. You can send Nick your questions at artoffindingwork@gmail.com.

Continue Reading

Trending